Jaclyn Ann Bennet

Publications

13

Citations

288

h-index

6

Publishing journals

12

Years of publications

20+

Active since

2020

References

222

Institutions

2

1. A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)
   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, No. ciag196, Year 2026
2. Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life.
   Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, Volume 34, Issue 6, Pages 1683-1694, Year 2025
3. Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial
   The Lancet HIV, Volume 11, Issue 7, Pages e436-e448, Year 2024
4. Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
   Nature Communications, Volume 15, Issue 1, Pages 9400-9400, Year 2024
5. Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study
   The Lancet Microbe, Volume 5, Issue 8, No. 100863, Page 100863, Year 2024
6. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
   Annals of Internal Medicine, Volume 176, Issue 5, Pages 658-666, Year 2023
7. Performance of spirometry assessment at TB diagnosis
   The International Journal of Tuberculosis and Lung Disease, Volume 27, Issue 11, Pages 850-857, Year 2023
8. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
   The Lancet, Volume 400, Issue 10366, Pages 1858-1868, Year 2022
9. A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
   The Lancet Gastroenterology & Hepatology, Volume 7, Issue 4, Pages 307-317, Year 2022
10. Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions
    Virus Evolution, Volume 7, Issue 2, No. A1347, Pages veab055-veab055, Year 2021
11. An incidental finding of chronic lymphocytic leukaemia in a patient with pulmonary tuberculosis
    Southern African Journal of Infectious Diseases, Volume 35, Issue 1, Year 2020
12. Cerebral vascular accidents after prophylactic central nervous system treatment during the course of acute lymphoblastic leukaemias and lymphomas.
    PubMed, Volume 23, Issue 2, Pages 81-6, Year 1980
13. [Acquired systemic hypervascularization of the lung].
    PubMed, Volume 23, Issue 4, Pages 371-83, Year 1970

No publications in the index yet.